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Emily Convery
Neuroscience 201
Deborah Cabin and her role in the research of Parkinson’s disease
Deborah Cabin received her PhD in physiology from Johns Hopkins University in 1996.
She has worked in research labs across America investigating genetic diseases and now is a
professor in structural and functional neuroscience at the University of Montana. Her interest in
Parkinson’s disease is a result of the complexity and mystery it presents to researchers. Since
2006, Deborah has made truly remarkable discoveries regarding the causes of the disease,
focusing in particular on a protein which is suspected to contribute significantly to the
development of Parkinson’s disease (PD). Her research aims to identify the normal role of this
protein, the mechanisms by which it leads to diseases, and to provide a progressive mouse model
to widen the scope of PD research.
What is Parkinson’s disease?
Parkinson’s disease is a hereditary neurological disorder which is polygenetic and
multifactorial. This means that mutations in an individual’s DNA lead to the disease by
impacting the peripheral and central nervous system. The combination of several effected genes
(polygenetic), with multiple environmental factors (multifactorial) cause the expression of PD
(1). PD is x-linked, and symptoms appear later in life, around age 40. The most apparent
symptom of Parkinson’s disease is hypokinesia, which includes slow movement, difficulty
initiating movement, rigidity (increased muscle tone), and tremors of the hands and jaw.
Impaired movement is caused by the loss of the neurotransmitter dopamine in the circuit that
allows the basal ganglia (more specifically, the substantia nigra) to communicate with the
striatum and area 6 of the motor cortex (2). The substantia nigra is a cell group in the mid-brain
that uses dopamine as a neurotransmitter and innervates the putamen (an area found in the
striatum). These two areas of the brain are essential for planning movement; the motor cortex is
located where signals encoding for what action is desired are converted into signals that specify
how the action will be executed. This is how the circuit works normally: When an action is
desired, excitatory inputs are sent from the motor cortex to the basal ganglia. These inputs then
project inhibitory neurons through the substantia nigra, activating cells in the putamen, which
send more inhibitory signals to the thalamus. The net reduction of inhibition removes the
suppression from the neurons in the thalamus, causing them to fire and to send movement-
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strategy information back to area 6 of the motor cortex (3). Area 6 of the motor cortex, or M1, is
essential for the planning and execution of movement for both sides of the body. The
neurotransmitter dopamine facilitates the motor loop by activating the cells in the putamen,
allowing for the movement of information from the substantia nigra to the thalamus and
eventually back to the motor cortex (fig.1) (2).
For patients with Parkinson’s disease, the loss of dopamine in this circuit results in
abnormal nerve-firing patterns and severely reduced capacity for planning, thus, executing
complex and simple movements. But the question is: why does the degeneration of dopaminergic
neurons take place?
A hallmark of Parkinson’s disease is the presence of Lewy bodies in the cell bodies of an
affected person’s neurons. Lewy bodies are peculiar deposits of the brain protein alphasynuclein, whose normal function and role in causing PD was unknown before Dr. Cabin’s
research.
The normal function of alpha-synuclein in neurons
Dr. Cabin and her research team at University of Montana needed to identify the normal
function of α-syn so as to be able to better identify its role in the formation of Lewy bodies and
ultimately its contribution to Parkinson’s disease. Using recombined homologous stem-cell
implants, they were able to generate mouse-models that completely lacked the protein (4). For
the first time, researchers were able to observe what happens in a brain with no α-syn. Electron
microscopy revealed strange behavior in synaptic vesicles in the neurons of the mouse’s
hippocampus. Synaptic vesicles are tiny hollow spheres located in the axons and axon terminals
on either side of a synaptic cleft (where chemical signals are sent and received between neurons)
and they store and transport neurotransmitters to neighboring neurons. Normal synaptic vesicles
undergo repeated steps of maneuvers, endocytosis, and exocytosis to complete the process of
intercellular communication (Fig. 2) (5). Vesicles are formed in the rough endoplasmic reticulum
of the soma, and the Golgi apparatus assigns it a neurotransmitter. Proteins embedded in the
vesicle membrane concentrate the neurotransmitter while it waits in the “reserve pool” located in
the axon. Once the traffic is clear, the vesicle is transported down to the axon terminal where it
releases its contents through the synaptic cleft to the next neuron (6). This is how neurons
communicate. The strange vesicle behavior observed by Dr. Cabin and her team was that in the
mice that lacked α-syn, vesicles in a non-docked position were significantly impaired by a

http://soundideas.pugetsound.edu/soundneuroscience/vol2/iss1/6

2

Convery: Deborah Cabin and Her Role in the Research of Parkinson’s Disease

repetitive high-frequency stimulation of 12.5 Hz for 300 pulses. Also, the replenishment of
docked vesicles after depletion took much longer in the mutant mouse synapses than in normal
mouse synapses (fig.3). This suggests that α-syn plays an important role in the generation or
maintenance of synaptic vesicles found in reserve pools of axon terminals (4). In the case of
Parkinson’s disease, this makes sense because a neuron’s decreased ability to produce normally
functioning synaptic vesicles will lead to a breakdown or loss of interneuron communication.
The mechanism by which α-synuclein contributes to disease
From the results of her mutant mouse experiment, Dr. Cabin was able to construct a basic
idea of what α-syn is and how it operates in the formation of Lewy bodies. Furthermore, research
was conducted in the attempt to explain why Lewy bodies are a contributing factor to
Parkinson’s disease. The evidence provided by the experiment (above) suggests that α-syn plays
a role in regulating membrane stability in vesicles and thus, overall neural plasticity. Neural
plasticity refers to the capacity of brain neurons to change pathways and to adapt to changes in a
person’s behavior or environment. Neural plasticity is also a required process to recover from a
traumatic brain injury (2). Mutations in the gene that code for α-syn production can lead to the
misfolding of the protein. Misfolding can cause the loss of normal functionality of α-syn and also
to the aggregation of α-syn in the soma of a neuron, also known as a Lewy body (3).
The Lewy body causes the disruption of vesicle formation, oxidative stress, dopaminergic
cell loss, and ultimately contributes to the expression of Parkinson’s disease (6). Oxidative stress
occurs when the cell body is unable to repair damage caused by oxidation (which is a normal
result of burning fuel for energy in the cell) at the rate at which it occurs. This imbalance can
cause the neuron to become toxic and die (2). When dopaminergic cells die, as discussed, the
pathway between the basal ganglia and the thalamus is weakened with each death. Thus, the
communication required within the brain to plan and execute movement is severely hindered,
and progresses over time.
Final remarks: further research
Dr. Cabin’s research of Parkinson’s disease provides probable answers to questions that
neuroscientists have been asking for decades. Identifying the function of the illusive α-synuclein
in normal brains allows us to delve deeper into its function in abnormal brains. However, since it
is an almost exclusively human protein which is complex and difficult to isolate, the
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development of an affective model for study is very hard to do. Dr. Cabin introduced the use of
the mutant human gene A53T alpha
alpha-synuclein
synuclein on embryonic mice, but would like to develop a
method (maybe using a prion-like
like nature of misfolded α-syn) to generate earlier onset of the
disease in the mice for further study (3).. This would be useful for identifying early bio-markers,
bio
and for testing treatment methods. Parkinson’s disease affects over 1 million Americans and an
estimated 7-10
10 million people worldwide, and Dr. Cabin’s research has undoubtedly raised our
knowledge about the disease and its causes to a new level. Dr. Cabin hopes to extend her
research to the role α-syn may play in Alzheimer’s disease.
Figures
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